Therapy Unblinded: Inside MDMA Research Part 2
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
Therapy Unblinded: Inside MDMA Research Part 2
-
Gesprochen von:
-
Von:
Über diesen Titel
Dr. Chantelle Thomas and Dr. Ingmar Gorman discuss the safety and ethical considerations of MDMA-assisted psychotherapy for PTSD, including standardization, non-directive approach, and adherence to therapy protocol. They also explore complex power dynamics in therapeutic relationships, ethical nuances of supporting participants in psychedelic studies, and the importance of representing a diverse population in psychedelic trials.
(00:00:00) Introduction
(00:10:30) Therapist-participant relationships in psychedelic-assisted therapy trial.
(00:14:58) Challenges in supporting participants in psychedelic studies after the end of the trial.
(00:23:11) Standardizing therapy for MDMA-assisted therapy trial.
(00:32:11) The importance of non-directional support.
(00:36:37) Operationalizing therapy techniques to ensure consistency and address power imbalances.
(00:43:06) Psychedelic therapy adherence and rating systems.
(00:50:08) Therapist flexibility in the trial.
(00:59:41) Inclusion of diverse participants.
Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/
Integrata: www.integratahealing.com
Dr. Ingmar Gorman: https://www.ingmargorman.com/about
Lykos: https://lykospbc.com
